ZNF426 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.192800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.859000E-01
Normal-vs-Stage2
2.036200E-01
Normal-vs-Stage3
2.325200E-01
Normal-vs-Stage4
8.068000E-01
Stage1-vs-Stage2
4.504400E-01
Stage1-vs-Stage3
9.254400E-02
Stage1-vs-Stage4
3.752400E-01
Stage2-vs-Stage3
7.59070000189155E-08
Stage2-vs-Stage4
4.879900E-02
Stage3-vs-Stage4
1.193430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.094000E-01
Normal-vs-AfricanAmerican
6.517400E-01
Normal-vs-Asian
1.587950E-01
Caucasian-vs-AfricanAmerican
4.429200E-01
Caucasian-vs-Asian
2.105200E-01
AfricanAmerican-vs-Asian
2.427800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.469030E-01
Normal-vs-Female
3.440200E-01
Male-vs-Female
1.156010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.554200E-01
Normal-vs-Age(41-60Yrs)
4.281800E-01
Normal-vs-Age(61-80Yrs)
1.735570E-01
Normal-vs-Age(81-100Yrs)
9.832200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.741600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.029000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.109000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.366500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.564100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.583000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.531900E-02
Normal-vs-Daily Drinker
4.379500E-02
Normal-vs-Weekly Drinker
3.213600E-01
Normal-vs-Occasional Drinker
2.981200E-01
Normal-vs-Social Drinker
6.517800E-01
Non Drinker-vs-Daily Drinker
5.794400E-01
Non Drinker-vs-Weekly Drinker
2.049000E-01
Non Drinker-vs-Occasional Drinker
1.408970E-01
Non Drinker-vs-Social Drinker
3.490400E-02
Daily Drinker-vs-Weekly Drinker
1.148410E-01
Daily Drinker-vs-Occasional Drinker
7.226400E-02
Daily Drinker-vs-Social Drinker
2.326400E-02
Weekly Drinker-vs-Occasional Drinker
9.501000E-01
Weekly Drinker-vs-Social Drinker
4.619000E-01
Occasional Drinker-vs-Social Drinker
4.486400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.456000E-01
Normal-vs-Grade 2
1.037380E-01
Normal-vs-Grade 3
7.864200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.342000E-01
Grade 1-vs-Grade 3
2.997400E-01
Grade 1-vs-Grade 4
2.456000E-01
Grade 2-vs-Grade 3
8.315800E-01
Grade 2-vs-Grade 4
1.037380E-01
Grade 3-vs-Grade 4
7.864200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.575000E-01
Normal-vs-NonDiabetic
1.161420E-01
Diabetic-vs-NonDiabetic
4.995000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.717700E-02
Normal-vs-NoPancreatitis
1.770950E-01
Pancreatitis-vs-NoPancreatitis
3.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.221800E-01
Normal-vs-N1
2.328000E-01
N0-vs-N1
7.026600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.381200E-01
Normal-vs-TP53-NonMutant
4.456800E-01
TP53-Mutant-vs-TP53-NonMutant
6.635600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
